Trial Profile
Pharmacokinetic study of valganciclovir for prevention of herpes virus infection in paediatric and adult solid organ transplant recipients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Herpesvirus infections
- Focus Pharmacokinetics
- 11 Dec 2015 New trial record
- 11 Jun 2011 Recruitment was completed, according to results published in the British Journal of Clinical Pharmacology.